While the South Korea and Thailand have achieved universal health...
Category:
Eco/Invest/Demography
Latest
Govt widens spices probe amid contamination concerns
India is the world's biggest exporter, producer and consumer of...
ADB ‘Vastly Overstated’ climate finance claims in Asia, says Oxfam
The ADB, however, reaffirmed its figures, standing by its...
DCGI and institutional ethics committee investigating claim of adverse event in COVID vaccine trial: Officials
A 40-year-old Chennai-based business consultant, who was a volunteer for the third phase of the vaccine trial conducted by Pune-based Serum Institute of India (SII), has sought Rs 5 crore compensation for allegedly suffering serious neurological and psychological symptoms after taking the dose
“It is evident that the intention behind the spreading of such malicious information is an oblique pecuniary motive. The Serum Institute of India, will seek damages in excess of 100 crore for the same and will defend such malicious claims,” Serum Institute said.
China scientists say the coronavirus may have originated in India
In May, the World Health Assembly (WHA), the governing body of the 194-member states of the WHO, approved a resolution to set up an independent inquiry to conduct an impartial, independent and comprehensive evaluation” of the international response as well as that of WHO.
Hacker selling CEO, CFO email accounts for as less as Rs 7,400
The data is being sold on a closed-access underground forum for Russian-speaking hackers called exploit.in”.
The high-level employees at risk include chief executive officers, chief operating officers, chief financial officers, chief marketing officers, chief technology officers, presidents, vice presidents and company directors, among others.
WHO says would be ‘highly speculative’ to say COVID did not emerge in China
China is pushing a narrative via state media that the virus existed abroad before it was discovered in the central city of Wuhan, citing the presence of coronavirus on imported frozen food packaging and scientific papers claiming it had been circulating in Europe last year.
“I think it’s highly speculative for us to say that the disease did not emerge in China,” Mike Ryan said at a virtual briefing in Geneva after being asked if COVID-19 could have first emerged outside China.
IRDAI approves swap of Mitsui Sumitomo’s Max Life stake with its listed parent
MFSL will now proceed for the implementation of the share swap transaction, which will entail swapping by MSI of its 20.57% stake in Max Life with a 21.87% stake in MFSL by way of issue and allotment of 7,54,58,088 equity shares of Rs. 2/- each at a price of Rs. 565.11 per equity share on a preferential allotment basis.
The share swap transaction will effectively result in MFSL’s stake in Max Life increasing to 93.10%. Presently, MFSL holds a 72.5% stake in Max Life and MSI owns 25.5% stake.
Home health care improves COVID-19 outcomes: Study
“Our findings suggest that acute care providers might carefully consider which COVID-19 survivors would benefit from home health care after hospitalization,” writes Kathryn H. Bowles, Ph.D., RN, FAAN, FACMI, Professor of Nursing and van Ameringen Chair in Nursing Excellence at Penn Nursing
“
SII to seek emergency-use authorisation of COVID-19 vaccine in 2-weeks:Poonawalla
“The vaccine will be distributed initially in India, and then we will look at the COVAX countries, mainly in Africa. The UK and European markets are being taken care of by AstraZeneca and Oxford. Our priority is India and COVAX countries,” he said, adding they can do under-18 trails after a few months.
h
UK regulator set to approve COVID-19 vaccine next week – FT
The government asked the regulator on Friday to assess AstraZeneca Plc’s COVID-19 vaccine for a possible rollout. It has secured 100 million doses of the vaccine developed by AstraZeneca and Oxford University and has targeted a rollout to begin before Christmas.
Apr-Sep FDI inflow climbs 15% to Rs 2.2 trillion; Mauritius was top source
Among the sectors, services sector continued to lead with the highest amount of FDI coming in. The sector which includes financial, banking, insurance, outsourcing, R&D among others, received 17 per cent of the FDI equity inflow during the period under review.
According to data from the Department for Promotion of Industry and Internal Trade (DPIIT), Mauritius and Singapore were the biggest sources of FDI for India with 29 per cent and 21 per cent contribution respectively.
The US, Netherlands and Japan followed with 7 per cent contribution each.
Govt”s ethanol push prompts sugar mills to raise production
Recently, the Union government had decided to allow use of old stock of wheat and rice for ethanol production that can be blended with petrol and diesel